Last reviewed · How we verify

NCT06110364

Vagal Nerve Stimulation as an Alternative Therapy for Premature Ventricular Contractions

Withdrawn Phase 3 Last updated 26 October 2024
What this trial tests

Phase 3 trial testing Low-Level Tragus Stimulation in Premature Ventricular Contraction. Withdrawn.

Timeline
19 July 2023
Primary endpoint
30 July 2024
13 August 2024

Quick facts

Lead sponsorHunter Holmes Mcguire Veteran Affairs Medical Center
PhasePhase 3
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposetreatment
Start date19 July 2023
Primary completion30 July 2024
Estimated completion13 August 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Hunter Holmes Mcguire Veteran Affairs Medical Center

Who can join

18 and older, any sex, with Premature Ventricular Contraction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective randomized control pilot study

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Premature Ventricular Contraction

Currently open trials in the same condition.

Other Hunter Holmes Mcguire Veteran Affairs Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06110364.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing